Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)

China · Delayed Price · Currency is CNY

50.66

+0.56 (1.12%)

At close: Feb 3, 2026

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Transformation of Independent Research and Development Technological Achievements	287.77M
Transformation of Independent Research and Development Technological Achievements Growth	-26.67%
Clinical Services	213.09M
Clinical Services Growth	10.48%
Preclinical Pharmaceutical Research	193.54M
Preclinical Pharmaceutical Research Growth	-42.76%
Customized Research and Development and Production	41.72M
Customized Research and Development and Production Growth	-20.52%
Commercial Production	36.69M
Equity Share	8.50M
Equity Share Growth	-71.32%
Other	20.61M
Other Growth	72.92%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	801.92M
China Growth	-21.18%